References
- Begnini KR, Nedel F, Lund RG, Carvalho PH, Rodrigues MR, Beira FT, Del-Pino FA. 2014. Composition and antiproliferative effect of essential oil of Origanum vulgare against tumor cell lines. Invest New Drugs. Oct;17:1129–1133.10.1089/jmf.2013.0063
- Houghton PMP. 2009. Evaluation of herbal medicinal products perspectives on quality, safety and efficacy. London: Pharmaceutical Press.
- Koldaş S, Demirtas I, Ozen T, Demirci MA, Behçet L. 2015. Phytochemical screening, anticancer and antioxidant activities of Origanum vulgare L. ssp. viride (Boiss.) Hayek, a plant of traditional usage. J Sci Food Agri. 95(4):786–798.10.1002/jsfa.2015.95.issue-4
- Mariniello B, Rosato A, Zuccolotto G, Rubin B, Cicala MV, Finco I, Iacobone M, Frigo AC, Fassina A, Pezzani R, et al. 2012. Combination of sorafenib and everolimus impacts therapeutically on adrenocortical tumor models. Endocrine Related Cancer. Aug;19:527–539.10.1530/ERC-11-0337
- Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS. 2011. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3 K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation . Cancer Letters. Dec 22;312:178–188.10.1016/j.canlet.2011.08.001
- Pezzani R, Rubin B, Bertazza L, Redaelli M, Barollo S, Monticelli H, Baldini E, Mian C, Mucignat C, Scaroni C, et al. 2016. The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line. Investigational New Drugs. Oct;34:531–540.10.1007/s10637-016-0358-3
- Pezzani R, Vitalini S, Iriti M. 2017. Bioactivities of Origanum vulgare L.: an update. Phytochem Rev. Sept;6:1253–1268.
- Savini I, Arnone R, Catani MV, Avigliano L. 2009. Origanum vulgare induces apoptosis in human colon cancer caco2 cells. Mol Cell Endocrinol.61:381–389.10.1080/01635580802582769
- Vaško L, Vašková J, Fejerčáková A, Mojžišová G, Poráčová J. 2014. Comparison of some antioxidant properties of plant extracts from Origanum vulgare, Salvia officinalis, Eleutherococcus senticosus and Stevia rebaudiana. In Vitro Cell Dev Biol-Animal. Aug;50:614–622.10.1007/s11626-014-9751-4
- Wang T, Rainey WE. 2012. Human adrenocortical carcinoma cell lines. Mole Cell Endocrinol. Mar 31;351:58–65.10.1016/j.mce.2011.08.041